Products Affected - Description
Ontak injection, 150 mcg/mL, Eisai
2 mL vial (NDC 62856-0603-01)
Reason for the Shortage
- Eisai is working to resolve a manufacturing problem.1
- Eisai is the sole manufacturer of denileukin diftitox.
No presentations are available.
Estimated Resupply Dates
Eisai has Ontak on back order and the company cannot estimate a release date.1
Implications for Patient Care
March 18 and 25, 2015; December 17, September 16, June 3, March 5, 2014; December 17, September 30, July 25, April 17, January 7, 2013; October 10, August 8, June 5, March 22, January 13, 2012; December 9, November 4, September 16, August 12, July 12, and June 28, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins